Enhanced Osteogenic Activity and Bone Repair Ability of PLGA/MBG Scaffolds Doped with ZIF-8 Nanoparticles Loaded with BMP-2
Rui Ma,Yanwen Su,Ruomu Cao,Kunzheng Wang,Pei Yang
DOI: https://doi.org/10.2147/IJN.S423985
IF: 7.033
2023-09-07
International Journal of Nanomedicine
Abstract:Rui Ma, 1, &ast Yanwen Su, 2, 3, &ast Ruomu Cao, 1 Kunzheng Wang, 1 Pei Yang 1 1 Department of Bone and Joint Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, 710004, People's Republic of China; 2 State Key Laboratory for Manufacturing Systems Engineering, Xi'an Jiaotong University, Xi'an, 710049, People's Republic of China; 3 National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Additive Manufacturing Medical Devices, Xi'an Jiaotong University, Xi'an, 710049, People's Republic of China &astThese authors contributed equally to this work Correspondence: Kunzheng Wang; Pei Yang, Email ; Background: Tissue engineering scaffolds are porous and can be loaded with growth factors to promote osteogenesis and bone repair, which can solve the problem of clinical bone defects. The direct loading of growth factors on scaffolds is hindered by the disadvantages of low loading capacities, and uncontrollable burst release. Zeolitic imidazolate framework-8 (ZIF-8) has osteoinductive activity and drug-loading potential and can be loaded with growth factors to achieve sustained release. In this study, we aimed to establish a sustained release system of composite scaffolds loaded with growth factors to achieve the goal of slow controlled release and effective bone repair. Methods: ZIF‐8 nanoparticles loaded with bone morphogenetic protein-2 (BMP-2) were incorporated into poly-(lactide-co-glycolide)/mesoporous bioactive glass (PLGA/MBG) porous scaffolds by a 3D-printing method. The surface morphology, chemical properties and BMP-2 release of the prepared scaffold were investigated. The osteoblast adhesion, proliferation, spreading, and osteogenic differentiation in vitro and the bone repair ability in vivo of the PLGA/MBG/ZIF-8/BMP-2 (PMZB) scaffold were evaluated, and compared with those of PLGA/MBG (PM) and PLGA/MBG/ZIF-8 (PMZ) scaffolds. Results: The results showed that the PMZB scaffold exhibited a slow and continuous BMP-2 release pattern, enhanced osteoblast adhesion, proliferation, spreading and osteogenic differentiation in vitro, and promoted new bone formation and bone repair in vivo. Conclusion: The PLGA/MBG/ZIF-8/BMP-2 porous scaffold could continuously and slowly release BMP-2, enhance osteogenic activity, and promote new bone formation and bone repair at bone defects. The PMZB scaffold can be used as a bone graft material to repair bone defect at non-weight-bearing sites. Keywords: bone repair, controlled release, zeolitic imidazolate frameworks-8, mesoporous bioactive glass, scaffold Bone defects caused by trauma, infection, tumors, and fracture nonunion are common in orthopedic clinics. Autologous or allogeneic bone grafts are usually used to restore the integrity of bone defects, but bone grafting is often restricted by limited tissue to harvest, reduced bioactivity, donor site morbidity, pathogen transmission risk and immune rejection. 1 Bone tissue engineering (BTE) scaffolds involve the use of biomaterials and growth factors that enhance cell differentiation, improve osteogenic activity and promote bone repair. 2,3 To fabricate BTE scaffolds, poly (lactide-co-glycolide) (PLGA), polycaprolactone (PCL) and polylactic acid (PLA) have been widely used for bone tissue regeneration. 4,5 Among these polymer biomaterials, PLGA exhibits good biodegradability and biocompatibility, 6,7 and an injectable PLGA-based formulation has been approved by the Food and Drug Administration (FDA) of US as injectable PLGA-based formulations. 8 However, pure PLGA for bone regeneration is hampered by poor osteoconductivity, low hydrophilicity and suboptimal mechanical properties for use in load-bearing applications, 6 and its acidic degradation byproducts can lead to a pH decrease in the vicinity of the implants. 9 3D-printed composites composed of biodegradable polymers and bioceramics can benefit from the advantages of both phases and can be tailored to mimic the native bone structure. 2,3,10 3D printed scaffolds play an essential role in supporting tissue reconstruction and remodeling. 10,11 As a classic type of bioceramic with a composition of CaO–SiO 2 –P 2 O 5 , mesoporous bioactive glasses (MBGs) possess favorable bioactivity and reasonable degradability. 12–15 MBG scaffolds have shown great potential for BTE and drug-delivery applications. 16,17 MBG incorporation improves the osteogenic ability of polymer-based composites. 9,18–21 Chen et al 21 prepared MBG-coated PLGA electrospun f -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology